Detalhe da pesquisa
1.
Protective effects of medium chain triglyceride diet in a mouse model of Dravet syndrome.
Epilepsia
; 62(12): 3131-3142, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34713469
2.
Neuronal decanoic acid oxidation is markedly lower than that of octanoic acid: A mechanistic insight into the medium-chain triglyceride ketogenic diet.
Epilepsia
; 58(8): 1423-1429, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28682459
3.
The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome.
J Inherit Metab Dis
; 39(3): 415-426, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27080638
4.
The ketogenic diet component decanoic acid increases mitochondrial citrate synthase and complex I activity in neuronal cells.
J Neurochem
; 129(3): 426-33, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24383952
5.
K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy.
Brain Commun
; 3(4): fcab160, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34729477
6.
A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model.
Oncotarget
; 8(39): 64728-64744, 2017 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029389
7.
The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome.
Oncotarget
; 8(34): 57201-57215, 2017 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28915665
8.
Mitochondria: The ketogenic diet--A metabolism-based therapy.
Int J Biochem Cell Biol
; 63: 55-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25666556